The announcement highlights NJF Holdings' strategic presence across two sectors that are increasingly interconnected but rarely addressed together. Through its venture investment arm, NJF Capital, the group has developed a portfolio of more than 40 technology and life sciences companies. Through Gameday by NJF Holdings, it has become one of Europe's most active investors in professional sports infrastructure. According to Junkermann, this dual presence provides NJF with a unique perspective on the growing convergence between sports and life sciences.
Junkermann emphasized that the science used to help athletes perform better, recover faster and extend their careers is fundamentally linked to the science aimed at improving healthy ageing for the broader population. She stated that India possesses the research talent, clinical infrastructure and commercial incentives required to become a global leader in both fields. She added that the opportunity lies in deliberately connecting these sectors rather than allowing them to develop independently.
A major factor driving this investment thesis is the rapid expansion of the global longevity economy. Analysts increasingly describe this sector as one of the defining economic trends of the coming decades, encompassing products, services and technologies designed to extend healthy human lifespan. The sector includes pharmaceuticals, diagnostics, wearable technologies, nutrition science, genetic research and rehabilitation technologies, and continues to attract significant investment worldwide.
Professional sports occupy a critical position within this evolving economy. Elite athletes often serve as real-world testing grounds for human performance optimisation, with innovations in recovery protocols, nutritional strategies, biomechanical analysis and injury prevention frequently transitioning into mainstream healthcare applications over time.
Junkermann believes India has a unique opportunity to accelerate this process and emerge not merely as a consumer of sports life sciences technologies developed elsewhere but as a leading creator and exporter of such innovations.
India already possesses several competitive advantages that support this ambition. The country is a global leader in pharmaceutical manufacturing, has a rapidly growing biotechnology and health technology ecosystem, benefits from a deep pool of engineering and scientific talent, and is witnessing the rapid expansion of professional sports leagues that increasingly demand advanced performance science solutions.
Junkermann also highlighted the important role professional sports leagues can play in building this ecosystem. She argued that leagues investing heavily in athlete health and performance science generate two significant benefits. They improve athlete performance through longer careers, lower injury rates and enhanced recovery, ultimately increasing the quality of competition and strengthening audience engagement, media value and sponsorship opportunities. At the same time, they generate valuable biomechanical, physiological and psychological data that can become a powerful research asset extending far beyond the sports industry itself.
She noted that leagues prioritising athlete health are not only making a responsible decision but are also creating long-term commercial value through performance data, clinical protocols and partnerships with life sciences companies. She pointed to developments in major global sporting organisations such as the NBA and Premier League, suggesting that Indian leagues have the opportunity to adopt this understanding from the outset rather than developing it later.
NJF Holdings is currently evaluating investment opportunities in India across multiple categories within this emerging sector. Areas under consideration include sports performance technology companies applying artificial intelligence and data science to athlete development, health technology platforms serving active populations, diagnostics and wearable technology firms whose products can be validated in professional sports before reaching consumer markets, and collaborative research initiatives between professional sports leagues and life sciences institutions.
Junkermann compared the opportunity to India's successful development of digital public infrastructure, particularly in payments and identity systems. She argued that India's rise in digital innovation resulted from a deliberate decision to build foundational infrastructure that enabled broad participation and encouraged private-sector innovation.
According to Junkermann, a similar strategy could position India as a global leader in sports life sciences. She stated that if the country deliberately develops infrastructure connecting professional sports, longevity research and consumer health, it could establish worldwide leadership in the sector within a decade. Conversely, she warned that allowing these industries to evolve separately could result in India spending years importing technologies developed elsewhere.
NJF Holdings has indicated that further details regarding specific investment activities in this area will be announced later in 2026.
NJF Holdings is a global investment group established by Nicole Junkermann and includes NJF Capital, which maintains investments in more than 40 technology, artificial intelligence and life sciences companies, and Gameday by NJF Holdings, a sports investment and platform business.
Among NJF Capital's notable investments are SpaceX, Revolut, Rippling and Groq, which was acquired by Nvidia. Gameday by NJF Holdings is also the largest shareholder in Italy's Lega Volley Femminile.
The development underscores growing global interest in the intersection of sports science, longevity research and health technology, while positioning India as a potential leader in a rapidly expanding sector that could reshape both professional athletics and the future of healthcare innovation.
About The Author
.jpg)
Comment List